Thursday, November 6, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Projections and Future Growth Predictions for Kroger

Elaine Mendonca by Elaine Mendonca
February 27, 2024
in Breaking News
0
DrugRetailers Stock Bull Market
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

Analyst Projections for Kroger

In the past few months, analysts have shared varying opinions on Kroger (NYSE: KR), ranging from optimistic to cautious. Here is a breakdown of recent ratings:

Total Ratings:
Bullish: 0
Somewhat Bullish: 2
Indifferent: 3
Somewhat Bearish: 0
Bearish: 0

Last 30 Days:
Bullish: 0
Somewhat Bullish: 0
Indifferent: 1
Somewhat Bearish: 0
Bearish: 0

1 Month Ago:
No changes in ratings.

2 Months Ago:
Somewhat Bullish: 1

3 Months Ago:
Indifferent: 2

Analysts have established a 12-month price target for Kroger, with an average target of $50.8, a high estimate of $55.00, and a low estimate of $46.00. Recent adjustments by key analysts include:

– Edward Kelly from Wells Fargo raised the rating to Equal-Weight with a current price target of $50.00.
– Joseph Feldman from Telsey Advisory Group maintained an Outperform rating with a price target of $55.00.
– Ken Goldman from JP Morgan lowered the rating to Overweight with a price target of $53.00.
– Simeon Gutman from Morgan Stanley lowered the rating to Equal-Weight with a price target of $46.00.
– Ben Bienvenu from Stephens & Co. lowered the rating to Equal-Weight with a price target of $50.00.

Analysts’ reactions reflect shifts in market conditions and Kroger’s performance, influencing their recommendations.

Future Growth Predictions

Analyst forecasts for Kroger point towards positive growth prospects:

– Kroger is expected to increase earnings and revenue by 11.7% and 1.4% per year, with an anticipated EPS growth rate of 13.2% annually.
– Return on equity is predicted to reach 18.8% in the next three years.

These projections indicate a favorable outlook for Kroger’s future performance and financial well-being.

Kroger Co. (KR) Stock Price Update: February 27, 2024 – Stability Amid Slight Drop

On February 27, 2024, Kroger Co. (KR) experienced a slight drop in its stock price, closing at $47.26, which was a decrease of $0.95 or 1.97% from the previous market close. However, the stock showed some positive momentum in pre-market trading, with a $0.30 increase. Despite the drop in stock price, KR is still trading in the middle of its 52-week range and above its 200-day simple moving average. This indicates that the stock has been relatively stable over the long term, which may provide some reassurance to investors.

Kroger Co. (KR) Reports Strong Financial Results with Impressive Revenue and Net Income Growth

Kroger Co. (KR) had a strong performance on February 27, 2024, as its stock showed positive movement following the release of its financial results. According to data from CNN Money, Kroger reported total revenue of $148.26 billion for the past year, with a slight increase of 7.52% compared to the previous year. The net income for Kroger also saw significant growth, with the company reporting $2.22 billion in net income for the past year, marking a 35.69% increase from the previous year. Earnings per share (EPS) for Kroger showed impressive growth as well, with the company reporting an EPS of $3.06 for the past year, reflecting a 40.73% increase from the previous year. Overall, Kroger’s strong financial performance for the past year and the third quarter indicates that the company is on a positive trajectory. Investors reacted positively to the news, driving the stock price higher on February 27, 2024. With a solid increase in total revenue, net income, and EPS, Kroger has demonstrated its ability to deliver strong financial results and create value for its shareholders.

Tags: KR
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
MMM stock news

Shift4 Payments Reports Lower Than Expected Quarterly Earnings But Shows Significant Growth

Radio telecommunications

American Tower Reports Strong Q4 2023 Results

Tokenized-security-technology

Bentley Systems Inc Projects Strong Financial Performance for Fiscal Year 2024

Recommended

Marvell Technology Stock

Marvell Technology Emerges as Key Player in AI Infrastructure Boom

1 month ago
Novo Nordisk Stock

Danish Pharma Giant Novo Nordisk Faces Diverging Analyst Views

1 month ago
Finance_Investment (5)

Anticipation Builds as FirstService Prepares to Release Quarterly Earnings Report

2 years ago
Viking Therapeutics Stock

Acquisition Speculation Fuels Viking Therapeutics Stock Surge

1 month ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

DuPont Faces Critical Test as Quarterly Results Loom

Sarepta Therapeutics Shares Plummet Following Critical Clinical Trial Failure

Emerson Electric’s Strategic Pivot Faces Market Scrutiny

EU Grant Provides Critical Boost for LanzaTech’s Carbon Recycling Technology

Is Darden Restaurants Facing a Critical Test?

Critical Juncture for USA Rare Earth as Earnings and Chinese Export Curbs Collide

Trending

BioNTech Stock
Analysis

BioNTech’s Crossroads: Navigating Losses Amid Cancer Research Promise

by Andreas Sommer
November 6, 2025
0

BioNTech presents investors with a complex financial picture marked by contradictory signals. The German biotech firm reported...

Illumina Stock

China Lifts Export Ban on Illumina’s DNA Sequencers, Sparking Market Rally

November 6, 2025
Iovance Stock

Iovance Faces Critical Test as Q3 Earnings Approach

November 6, 2025
DuPont de Nemours Stock

DuPont Faces Critical Test as Quarterly Results Loom

November 6, 2025
Sarepta Therapeutics Stock

Sarepta Therapeutics Shares Plummet Following Critical Clinical Trial Failure

November 6, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • BioNTech’s Crossroads: Navigating Losses Amid Cancer Research Promise
  • China Lifts Export Ban on Illumina’s DNA Sequencers, Sparking Market Rally
  • Iovance Faces Critical Test as Q3 Earnings Approach

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com